NO955262L - N-substituerte azaheterosykliske karboksylsyrer og estere derav - Google Patents

N-substituerte azaheterosykliske karboksylsyrer og estere derav

Info

Publication number
NO955262L
NO955262L NO955262A NO955262A NO955262L NO 955262 L NO955262 L NO 955262L NO 955262 A NO955262 A NO 955262A NO 955262 A NO955262 A NO 955262A NO 955262 L NO955262 L NO 955262L
Authority
NO
Norway
Prior art keywords
phenyl
substituted
esters
carboxylic acids
compounds
Prior art date
Application number
NO955262A
Other languages
English (en)
Norwegian (no)
Other versions
NO955262D0 (no
Inventor
Per Olaf Soerensen
Jesper Lau
Knud Erik Andersen
Hans Petersen
Behrend Friedrich Lundt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO955262D0 publication Critical patent/NO955262D0/no
Publication of NO955262L publication Critical patent/NO955262L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO955262A 1993-06-23 1995-12-22 N-substituerte azaheterosykliske karboksylsyrer og estere derav NO955262L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93745A DK74593D0 (da) 1993-06-23 1993-06-23 Novel heterocyclic chemistry
PCT/DK1994/000252 WO1995000485A1 (en) 1993-06-23 1994-06-22 N-substituted azaheterocyclic carboxylic acids and esters thereof

Publications (2)

Publication Number Publication Date
NO955262D0 NO955262D0 (no) 1995-12-22
NO955262L true NO955262L (no) 1996-02-22

Family

ID=8097055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955262A NO955262L (no) 1993-06-23 1995-12-22 N-substituerte azaheterosykliske karboksylsyrer og estere derav

Country Status (16)

Country Link
US (1) US5635518A (ja)
EP (1) EP0705247A1 (ja)
JP (1) JPH08511782A (ja)
CN (1) CN1128988A (ja)
AU (1) AU6996194A (ja)
BG (1) BG100249A (ja)
CA (1) CA2165947A1 (ja)
CZ (1) CZ335095A3 (ja)
DK (1) DK74593D0 (ja)
FI (1) FI956176A (ja)
HU (1) HUT73243A (ja)
IL (1) IL110077A0 (ja)
NO (1) NO955262L (ja)
SK (1) SK162295A3 (ja)
WO (1) WO1995000485A1 (ja)
ZA (1) ZA944469B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ－氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
EP0252876A1 (de) * 1986-06-26 1988-01-13 Ciba-Geigy Ag Hydrierte 1-Phenoxyalkylpyridin-3-carbonsäureverbindungen

Also Published As

Publication number Publication date
ZA944469B (en) 1995-12-22
JPH08511782A (ja) 1996-12-10
NO955262D0 (no) 1995-12-22
SK162295A3 (en) 1996-09-04
FI956176A (fi) 1996-02-21
CN1128988A (zh) 1996-08-14
WO1995000485A1 (en) 1995-01-05
CZ335095A3 (en) 1996-08-14
EP0705247A1 (en) 1996-04-10
HUT73243A (en) 1996-07-29
AU6996194A (en) 1995-01-17
IL110077A0 (en) 1994-10-07
US5635518A (en) 1997-06-03
BG100249A (en) 1996-07-31
DK74593D0 (da) 1993-06-23
HU9503752D0 (en) 1996-02-28
CA2165947A1 (en) 1995-01-05
FI956176A0 (fi) 1995-12-21

Similar Documents

Publication Publication Date Title
DE69010375T2 (de) Protease-Hemmer.
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
PE59099A1 (es) Nuevos derivados del acido hexanoico
TW345575B (en) Pharmaceutical composition comprising an inhibitor for ras farnesylation and the preparation of the inhibitor compound
DE69516394D1 (de) Neue heterocyclische verbindungen
DK0607775T3 (da) Anvendelse af leflunomid til inhibering af interleukin 1 beta
DE3763863D1 (de) Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
NO176603C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive 8-substituert-2-aminotetraliner
PT89170A (pt) Processo de preparacao de compostos de imidazoquinoxalina terapeuticamente activos e de composicoes farmaceuticas que os contem
CA2174544A1 (en) Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents
BG51155A3 (en) Process for preparing a naphthalene derivatives
NO955262L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
NO955263L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
TNSN92017A1 (fr) Procede de preparation, d'un derive de benzothiazole, et d'une composition pharmaceutique le contenant et procede de traitement en comportant application
ATE90937T1 (de) Neue 3-methoximinopropionsaeureester und diese enthaltende fungizide.
DE69923838D1 (de) Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
ATE124685T1 (de) 4-phenylmethyl-1h-indol-derivate, verfahren und zwischenverbindungen zu deren herstellung, anwendung als arzneimittel und diese enthaltende zusammensetzungen.
DE3750464D1 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
NO955261L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE69810651D1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
FR2609603B1 (fr) Agents edulcorants derives des acides guanidinoacetique et ethanamidinoacetique, procede pour edulcorer des produits divers, et compositions contenant de tels agents edulcorants
DE69126326D1 (de) Verfahren und Zwischenprodukte zur Herstellung von anxiolytisch wirksamen Perhydro-1H-pyrido[1,2-a]pyrazinen